this is big news for biota - a massive market with a large part of the pop which can afford the product.
IMO demand from china alone could easily soak up all of gsks 190,000 doses/yr.
- Forums
- ASX - By Stock
- relenza approved for sale in china
this is big news for biota - a massive market with a large part...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)